Molecular pathology of lung cancer and its clinical relevance.

Philip T. Cagle

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations


Evidence indicates that several molecular genetic markers involved in the initiation and progression of lung cancer are useful in predicting prognosis in early stage lung cancer, thus allowing selection of subsets of patients for additional therapy and are likely to be useful in the diagnosis of malignancy in equivocal biopsies and cytology specimens. In the future, these markers may also prove to be useful in the early detection of lung cancer and in predicting response to specific therapies. Most of these markers can already be assessed by routine immunohistochemical techniques on paraffin-embedded tissue and development of antibodies to other markers is currently underway. The use of immunohistochemistry for evaluating these markers permits direct visualization of the tumor to avoid errors of sample size and contamination inherent in traditional molecular techniques and is a rapid, well-established technique familiar and available to surgical pathologists.

Original languageEnglish (US)
Pages (from-to)134-144
Number of pages11
JournalMonographs in pathology
Issue number36
StatePublished - Jan 1 1993

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Molecular pathology of lung cancer and its clinical relevance.'. Together they form a unique fingerprint.

Cite this